Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized …

GN Predy, V Goel, R Lovlin, A Donner, L Stitt, TK Basu - Cmaj, 2005 - Can Med Assoc
Background: Upper respiratory tract infections are a major source of morbidity throughout
the world. Extracts of the root of North American ginseng (Panax quinquefolium) have been …

[HTML][HTML] Efficacy and safety of CVT-E002, a proprietary extract of Panax quinquefolius in the prevention of respiratory infections in influenza-vaccinated community …

…, AE Simor, S McNeil, GN Predy - Influenza research and …, 2011 - hindawi.com
CVT-E002 (a proprietary extract) was found to be effective in the prevention of upper respiratory
infections (URIs) in healthy adults, and institutionalized and community-dwelling seniors…

Caremap management for postoperative prostatectomy care at home: a comparative study

…, CJ Raiwet, MG Grace, GN Predy… - Canadian journal of …, 1997 - ncbi.nlm.nih.gov
… RÉSULTATS : La comparaison entre les deux groupes n’a révélé aucune différence
importante en ce qui concerne les réhospitalisations, la réutilisation de services de soins de …

Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory …

SA Halperin, B Ward, C Cooper, G Predy… - Vaccine, 2012 - Elsevier
BACKGROUND: The currently licensed aluminum-hydroxide-adjuvanted hepatitis B vaccines
require three doses over a 6-month period to achieve high rates of protection in adults. We …

Health promotion and disease prevention in the emergency department: a feasibility study

GE Cummings, LH Francescutti, G Predy… - Canadian Journal of …, 2006 - cambridge.org
Background:Health promotion and disease prevention have been increasingly recognized
as activities that may be within the scope of emergency medicine. The purpose of this …

A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults≥ 65 years of age

JM Langley, V Sales, A McGeer, R Guasparini, G Predy… - Vaccine, 2009 - Elsevier
We studied the safety and immunogenicity of a Respiratory Syncytial Virus (RSV)-A vaccine
containing subunit antigens F, G and M in older persons, and its effect on influenza vaccine …

Safety and immunogenicity of a measles–mumps–rubella–varicella vaccine given as a second dose in children up to six years of age

SA Halperin, G Ferrera, D Scheifele, G Predy, G Stella… - Vaccine, 2009 - Elsevier
Two doses of measles–mumps–rubella vaccine (MMR) are widely recommended and
consideration is being given to a similar schedule for varicella vaccine. A combined measles–…

The responses of Aboriginal Canadians to adjuvanted pandemic (H1N1) 2009 influenza vaccine

E Rubinstein, G Predy, L Sauvé, GW Hammond, F Aoki… - Cmaj, 2011 - Can Med Assoc
Background: Because many Aboriginal Canadians had severe cases of pandemic (H1N1)
2009 influenza, they were given priority access to vaccine. However, it was not known if the …

Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined …

SA McNeil, F Noya, M Dionne, G Predy, W Meekison… - Vaccine, 2007 - Elsevier
The annual contact for influenza vaccination provides an opportunity to ensure that adults
have received other recommended vaccines such as Tdap. Healthy 19–64 year-olds were …

An adolescent–adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less …

JM Langley, G Predy, R Guasparini, B Law… - Vaccine, 2007 - Elsevier
In Canada, the fifth dose of the routine childhood immunization schedule against diphtheria,
tetanus, pertussis and polio is given at 4–6 years of age. Up to 30% of children may have …